Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Correlation between venous pressure gradients and intravascular ultrasound in the diagnosis of iliac vein compression syndrome.

Lorenção de Almeida B, Rossi FH, Guerra de Moraes Rego Sousa A, Kambara AM, Izukawa NM, Beteli CB, Andrade Cavalcante SF, Rodrigues TO, Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):492-499. doi: 10.1016/j.jvsv.2017.11.015. Epub 2018 Mar 8.

PMID:
29526687
2.

May-Thurner: diagnosis and endovascular management.

Knuttinen MG, Naidu S, Oklu R, Kriegshauser S, Eversman W, Rotellini L, Thorpe PE.

Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S159-S164. doi: 10.21037/cdt.2017.10.14. Review.

3.

Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.

Rossi FH, Kambara AM, Izukawa NM, Rodrigues TO, Rossi CB, Sousa AG, Metzger PB, Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):183-191. doi: 10.1016/j.jvsv.2017.11.003. Epub 2017 Dec 29.

PMID:
29292114
4.

Protective Effect of Anti-Phosphatidylserine Antibody in a Guinea Pig Model of Advanced Hemorrhagic Arenavirus Infection.

Thomas JM, Thorpe PE.

Open Microbiol J. 2017 Oct 30;11:303-315. doi: 10.2174/1874285801711010303. eCollection 2017.

5.

Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco.

Wojtukiewicz MZ, Sierko E, Skalij P, Kamińska M, Zimnoch L, Brekken RA, Thorpe PE.

Adv Clin Exp Med. 2016 May-Jun;25(3):505-11. doi: 10.17219/acem/62398.

6.

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.

Mineo C, Lanier L, Jung E, Sengupta S, Ulrich V, Sacharidou A, Tarango C, Osunbunmi O, Shen YM, Salmon JE, Brekken RA, Huang X, Thorpe PE, Shaul PW.

PLoS One. 2016 Jul 27;11(7):e0158757. doi: 10.1371/journal.pone.0158757. eCollection 2016.

7.

Criteria for detecting significant chronic iliac venous obstructions with duplex ultrasound.

Metzger PB, Rossi FH, Kambara AM, Izukawa NM, Saleh MH, Pinto IM, Amorim JE, Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2016 Jan;4(1):18-27. doi: 10.1016/j.jvsv.2015.07.002. Epub 2015 Sep 12.

PMID:
26946891
8.

Antibody-Mediated Blockade of Phosphatidylserine Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinomas Xenografts.

Cheng X, Li L, Thorpe PE, Yopp AC, Brekken RA, Huang X.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):583-591. Epub 2016 Feb 4.

PMID:
26847681
9.

Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts.

Gerber DE, Hao G, Watkins L, Stafford JH, Anderson J, Holbein B, Öz OK, Mathews D, Thorpe PE, Hassan G, Kumar A, Brekken RA, Sun X.

Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):493-503. eCollection 2015.

10.

Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation.

Yin Y, Huang X, Lynn KD, Thorpe PE.

Cancer Immunol Res. 2013 Oct;1(4):256-68. doi: 10.1158/2326-6066.CIR-13-0073. Epub 2013 Aug 19.

11.

A novel "salting-out" procedure for the isolation of tumor-derived exosomes.

Brownlee Z, Lynn KD, Thorpe PE, Schroit AJ.

J Immunol Methods. 2014 May;407:120-6. doi: 10.1016/j.jim.2014.04.003. Epub 2014 Apr 13.

12.

Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging.

Zhou H, Stafford JH, Hallac RR, Zhang L, Huang G, Mason RP, Gao J, Thorpe PE, Zhao D.

J Biomed Nanotechnol. 2014 May;10(5):846-55.

PMID:
24734537
13.

Identification and Treatment of Restenosis in Failing Venous Stents: The Role of Intravascular Ultrasound.

Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):109-10. doi: 10.1016/j.jvsv.2013.10.020. Epub 2013 Dec 12. No abstract available.

PMID:
26992995
14.

Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserine.

Stafford JH, Hao G, Best AM, Sun X, Thorpe PE.

PLoS One. 2013 Dec 19;8(12):e84864. doi: 10.1371/journal.pone.0084864. eCollection 2013.

15.

Inferior Vena Cava Endovascular Reconstructions: Fifteen Years of Experience.

Osse FJ Sr, Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2013 Jan;1(1):110. doi: 10.1016/j.jvsv.2012.10.035. Epub 2012 Dec 8. No abstract available.

PMID:
26993933
16.

Blood Type and Postthrombotic Syndrome: Early Indication for Endovascular Treatment.

Osse FJ Sr, Thorpe PE.

J Vasc Surg Venous Lymphat Disord. 2013 Jan;1(1):109-10. doi: 10.1016/j.jvsv.2012.10.034. Epub 2012 Dec 8. No abstract available.

PMID:
26993932
17.

Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function.

Wanderley JLM, Thorpe PE, Barcinski MA, Soong L.

Parasite Immunol. 2013 Mar-Apr;35(3-4):109-119. doi: 10.1111/pim.12019.

18.

Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel.

Mohamedali KA, Niu G, Luster TA, Thorpe PE, Gao H, Chen X, Rosenblum MG.

Biochem Pharmacol. 2012 Dec 1;84(11):1534-40. doi: 10.1016/j.bcp.2012.09.017. Epub 2012 Sep 26.

19.

IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.

Marquardt J, Begent RH, Chester K, Huston JS, Bradbury A, Scott JK, Thorpe PE, Veldman T, Reichert JM, Weiner LM.

MAbs. 2012 Nov-Dec;4(6):648-52. doi: 10.4161/mabs.22221. Epub 2012 Sep 24.

20.

Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery.

Judy BF, Aliperti LA, Predina JD, Levine D, Kapoor V, Thorpe PE, Albelda SM, Singhal S.

Neoplasia. 2012 Apr;14(4):352-9.

21.

Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model.

Zhao D, Stafford JH, Zhou H, Thorpe PE.

Transl Oncol. 2011 Dec;4(6):355-64. Epub 2011 Dec 1.

22.

Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1.

Kirov A, Al-Hashimi H, Solomon P, Mazur C, Thorpe PE, Sims PJ, Tarantini F, Kumar TK, Prudovsky I.

J Cell Biochem. 2012 Mar;113(3):956-66. doi: 10.1002/jcb.23425.

23.

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors.

Gerber DE, Stopeck AT, Wong L, Rosen LS, Thorpe PE, Shan JS, Ibrahim NK.

Clin Cancer Res. 2011 Nov 1;17(21):6888-96. doi: 10.1158/1078-0432.CCR-11-1074. Epub 2011 Oct 11.

24.

Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2.

Mohamedali KA, Ran S, Gomez-Manzano C, Ramdas L, Xu J, Kim S, Cheung LH, Hittelman WN, Zhang W, Waltenberger J, Thorpe PE, Rosenblum MG.

BMC Cancer. 2011 Aug 17;11:358. doi: 10.1186/1471-2407-11-358.

25.

Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment.

DeRose P, Thorpe PE, Gerber DE.

Immunotherapy. 2011 Aug;3(8):933-44. doi: 10.2217/imt.11.87. Review.

PMID:
21843081
26.

Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.

Huang X, Ye D, Thorpe PE.

Vaccine. 2011 Jun 24;29(29-30):4785-93. doi: 10.1016/j.vaccine.2011.04.082. Epub 2011 May 8.

PMID:
21557977
27.

Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer.

Sierko E, Wojtukiewicz MZ, Zimnoch L, Thorpe PE, Brekken RA, Kisiel W.

Anticancer Res. 2011 Mar;31(3):843-7.

PMID:
21498704
28.
29.

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, Herz J, Urbanus RT, de Groot PG, Thorpe PE, Salmon JE, Shaul PW, Mineo C.

J Clin Invest. 2011 Jan;121(1):120-31. doi: 10.1172/JCI39828. Epub 2010 Dec 1.

30.

Targeting anionic phospholipids on tumor blood vessels and tumor cells.

Thorpe PE.

Thromb Res. 2010 Apr;125 Suppl 2:S134-7. doi: 10.1016/S0049-3848(10)70031-1. No abstract available.

PMID:
20433993
31.

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines.

Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, Kozink DM, Drinker MS, Zhang R, Xia SM, Sutherland LL, Tomaras GD, Giles IP, Kappes JC, Ochsenbauer-Jambor C, Edmonds TG, Soares M, Barbero G, Forthal DN, Landucci G, Chang C, King SW, Kavlie A, Denny TN, Hwang KK, Chen PP, Thorpe PE, Montefiori DC, Haynes BF.

J Exp Med. 2010 Apr 12;207(4):763-76. doi: 10.1084/jem.20091281. Epub 2010 Apr 5.

32.

Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM.

Breast Cancer Res Treat. 2011 Jan;125(2):407-20. doi: 10.1007/s10549-010-0851-x. Epub 2010 Mar 27.

33.

Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma.

He J, Yin Y, Luster TA, Watkins L, Thorpe PE.

Clin Cancer Res. 2009 Nov 15;15(22):6871-80. doi: 10.1158/1078-0432.CCR-09-1499. Epub 2009 Nov 3.

34.

Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.

Mouta-Bellum C, Kirov A, Miceli-Libby L, Mancini ML, Petrova TV, Liaw L, Prudovsky I, Thorpe PE, Miura N, Cantley LC, Alitalo K, Fruman DA, Vary CP.

Dev Dyn. 2009 Oct;238(10):2670-9. doi: 10.1002/dvdy.22078.

35.

Reporting standards for endovascular treatment of lower extremity deep vein thrombosis.

Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, Janne d'Othée BM, Hofmann LV, Cardella JF, Kundu S, Lewis CA, Schwartzberg MS, Min RJ, Sacks D; Technology Assessment Committee of the Society of Interventional Radiology.

J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S391-408. doi: 10.1016/j.jvir.2009.04.034. No abstract available.

PMID:
19560027
36.

Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal.

Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H, Hofmann LV, Janne d'Othée BM, Antonaci VP, Brountzos EN, Brown DB, Martin LG, Matsumoto AH, Meranze SG, Miller DL, Millward SF, Min RJ, Neithamer CD Jr, Rajan DK, Rholl KS, Schwartzberg MS, Swan TL, Towbin RB, Wiechmann BN, Sacks D; CIRSE and SIR Standards of Practice Committees.

J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S227-39. doi: 10.1016/j.jvir.2009.04.016. No abstract available.

PMID:
19560003
37.

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.

Brown DB, Cardella JF, Sacks D, Goldberg SN, Gervais DA, Rajan DK, Vedantham S, Miller DL, Brountzos EN, Grassi CJ, Towbin RB; SIR Standards of Practice Committee, Angle JF, Balter S, Clark TW, Cole PE, Drescher P, Freeman NJ, Georgia JD, Haskal Z, Hovsepian DM, Kilnani NM, Kundu S, Malloy PC, Martin LG, McGraw JK, Meranze SG, Meyers PM, Millward SF, Murphy K, Neithamer CD Jr, Omary RA, Patel NH, Roberts AC, Schwartzberg MS, Siskin GP, Smouse HR, Swan TL, Thorpe PE, Vesely TM, Wagner LK, Wiechmann BN, Bakal CW, Lewis CA, Nemcek AA Jr, Rholl KS.

J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S219-S226, S226.e1-10. doi: 10.1016/j.jvir.2009.04.033. No abstract available.

PMID:
19560002
38.

Quality improvement guidelines for percutaneous management of acute limb ischemia.

Rajan DK, Patel NH, Valji K, Cardella JF, Brown DB, Brountzos EN, Clark TW, Grassi CJ, Meranze SG, Miller DL, Neithamer CD, Rholl K, Roberts A, Schwartzberg MS, Swan TT, Thorpe PE, Towbin RB, Sacks D; CIRSE and SIR Standards of Practice Committees.

J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S208-18. doi: 10.1016/j.jvir.2009.04.010. No abstract available.

PMID:
19560001
39.

Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4.

Donnini S, Solito R, Monti M, Balduini W, Carloni S, Cimino M, Bampton ET, Pinon LG, Nicotera P, Thorpe PE, Ziche M.

Cell Cycle. 2009 Apr 15;8(8):1271-8. Epub 2009 Apr 26.

PMID:
19305142
40.

Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases.

Soares MM, King SW, Thorpe PE.

Nat Med. 2008 Dec;14(12):1357-62. doi: 10.1038/nm.1885. Epub 2008 Nov 23.

41.

Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells.

Marconescu A, Thorpe PE.

Biochim Biophys Acta. 2008 Oct;1778(10):2217-24. doi: 10.1016/j.bbamem.2008.05.006. Epub 2008 May 28.

42.

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Kodibagkar VD, O'Kelly S, Kulkarni P, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE.

Clin Cancer Res. 2008 Mar 1;14(5):1377-85. doi: 10.1158/1078-0432.CCR-07-1516.

43.
44.

TAT-BH4 counteracts Abeta toxicity on capillary endothelium.

Cantara S, Thorpe PE, Ziche M, Donnini S.

FEBS Lett. 2007 Feb 20;581(4):702-6. Epub 2007 Jan 24.

45.

Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.

Mohamedali KA, Poblenz AT, Sikes CR, Navone NM, Thorpe PE, Darnay BG, Rosenblum MG.

Cancer Res. 2006 Nov 15;66(22):10919-28.

46.

Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells.

Luster TA, He J, Huang X, Maiti SN, Schroit AJ, de Groot PG, Thorpe PE.

J Biol Chem. 2006 Oct 6;281(40):29863-71. Epub 2006 Aug 10.

47.

Racing prognosis of horses following surgically repaired olecranon fractures.

Janicek JC, Rodgerson DH, Hunt RJ, Spirito MA, Thorpe PE, Tessman RK.

Can Vet J. 2006 Mar;47(3):241-5.

48.

Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal.

Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H, Hofmann LV, Janne d'Othée BM, Antonaci VP, Brountzos EN, Brown DB, Martin LG, Matsumoto AH, Meranze SG, Miller DL, Millward SF, Min RJ, Neithamer CD Jr, Rajan DK, Rholl KS, Schwartzberg MS, Swan TL, Towbin RB, Wiechmann BN, Sacks D.

J Vasc Interv Radiol. 2006 Mar;17(3):435-47; quiz 448. No abstract available.

PMID:
16567668
49.

Reporting standards for endovascular treatment of lower extremity deep vein thrombosis.

Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, Janne d'Othée BM, Hofmann LV, Cardella JF, Kundu S, Lewis CA, Schwartzberg MS, Min RJ, Sacks D; Technology Assessment Committe of the Society of Interventional Radiology.

J Vasc Interv Radiol. 2006 Mar;17(3):417-34. No abstract available.

PMID:
16567667
50.

Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice.

Beck AW, Luster TA, Miller AF, Holloway SE, Conner CR, Barnett CC, Thorpe PE, Fleming JB, Brekken RA.

Int J Cancer. 2006 May 15;118(10):2639-43.

Supplemental Content

Loading ...
Support Center